Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announced that it has expanded its Singapore facility, which recently received GMP approval from the Health Science Authority, to provide secondary packaging and labeling capabilities. The site is now fully approved for GMP across all its activities, including secondary packaging, label printing, storage, distribution, returns and destruction management.	 	

News

Catalent Singapore facility is awarded GMP certification.